Stock listing
0UNL Stock Price, News, Filings & Events — Nektar Therapeutics
Selected listing: 0UNL · LSE · USD · GB
This page tracks Nektar Therapeutics's 0UNL:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0UNL:LSE. 0UNL:LSE is the stock-level entry point for investors researching Nektar Therapeutics, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- 0UNL:LSE
- Asset type
- Stock
- Market cap
- $2.53B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- LSE
- Currency
- USD
Nektar Therapeutics 0UNL:LSE stock context
This page tracks Nektar Therapeutics's 0UNL:LSE listing on LSE in USD for GB, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following 0UNL:LSE. 0UNL:LSE is the stock-level entry point for investors researching Nektar Therapeutics, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Nektar Therapeutics
Nektar Announces Publication in The Lancet of Positive Phase 2b REZOLVE-AD 16-Week Induction Results of Rezpegaldesleukin in Moderate-to-...
August 25, 2026
Nektar Therapeutics Announces Second Quarter 2026 Financial Results
August 13, 2026
Nektar Therapeutics to Announce Financial Results for the Second Quarter on Thursday, August 13, 2026, After Close of U.S.-Based Financia...
July 28, 2026
Nektar Therapeutics Announces Start of Phase 3 ZENITH AD Program Evaluating Novel Regulatory T-Cell Biologic Rezpegaldesleukin in Moderat...
July 21, 2026
Nektar Therapeutics : Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 26, 2026
Research Nektar Therapeutics
Nektar Therapeutics investor report
Review AI stock analysis and investor report context for 0UNL:LSE.
Nektar Therapeutics company profile
View the public company page for Nektar Therapeutics on 6ix.
Nektar Therapeutics news
Read company news and market updates connected to Nektar Therapeutics.
Nektar Therapeutics investor events
Find investor webinars, events, and replay context for Nektar Therapeutics.
Alternate listings
NKTR:NASDAQ
US · USD
Alternate listing for Nektar Therapeutics; the primary context on this page is 0UNL:LSE.
ITH0:GETTEX
DE · EUR
Alternate listing for Nektar Therapeutics; the primary context on this page is 0UNL:LSE.
A419UB:LSX
DE · EUR
Alternate listing for Nektar Therapeutics; the primary context on this page is 0UNL:LSE.
ITH0:TRADEGATE
DE · EUR
Alternate listing for Nektar Therapeutics; the primary context on this page is 0UNL:LSE.
A419UB:LS
DE · EUR
Alternate listing for Nektar Therapeutics; the primary context on this page is 0UNL:LSE.
NKTR:BMV
MX · MXN
Alternate listing for Nektar Therapeutics; the primary context on this page is 0UNL:LSE.
NKTR:BIVA
MX · MXN
Alternate listing for Nektar Therapeutics; the primary context on this page is 0UNL:LSE.
NKTR:BOATS
US · USD
Alternate listing for Nektar Therapeutics; the primary context on this page is 0UNL:LSE.
NKTR:BX
CH · CHF
Alternate listing for Nektar Therapeutics; the primary context on this page is 0UNL:LSE.
ITH0:DUS
DE · EUR
Alternate listing for Nektar Therapeutics; the primary context on this page is 0UNL:LSE.
ITH0:FWB
DE · EUR
Alternate listing for Nektar Therapeutics; the primary context on this page is 0UNL:LSE.
ITH0:HAM
DE · EUR
Alternate listing for Nektar Therapeutics; the primary context on this page is 0UNL:LSE.